CLICKHERETO DOWNLOAD

SUBLOCADEisforsubcutaneousinjectiononly()TherecommendeddoseofSUBLOCADEistwomonthlyinitialdosesofmgfollowedbymgmonthly maintenancedoses.WHATISSUBLOCADE?(), STEPINJECTTHEMEDICATION.Specificallydiscusssafetyconcerns:Understandthatdiscontinuing buprenorphineincreasesriskofoverdosedeathuponreturntoillicitopioiduseSublocadeisaninjectableversionofbuprenorphinethatisinjectedonceamonth subcutaneously(justbelowtheskinoftheabdomen)()TherecommendeddoseofSUBLOCADEistwomonthlyinitialdosesofmgfollowedbymgmonthly maintenancedoses()SUBLOCADEisadministeredmonthlyonlybysubcutaneousinjectioninDonotinjectintravenously,intramuscularly,orintradermally[see WarningsandPrecautions(,)]()IncreasingthemaintenancedosetomgToreportapregnancyorsideeffectsassociatedwithtakingSUBLOCADEoranysafety relatedinformation,productcomplaint,requestformedicalinformation,orproductquery,pleasecontactPatientSafetyNA@orYouareencouragedtoreport negativesideeffectsofdrugstotheFDAWhatisSublocade?()SUBLOCADEisadministeredmonthlyonlybysubcutaneousinjectionintheabdominalregion. Issued/Formoreinformation,gotoorcallThisMedicationGuidehasbeenapprovedbytheU.S.FoodandDrugAdministration.Manypeopleknow buprenorphinebythebrandnameSuboxone,whichisatablettakendailyunderthetongueSUBLOCADEshouldonlybepreparedandadministeredbya healthcareproviderActualangleofinjectionwilldependontheamountofsubcutaneoustissueQUICKSTARTGUIDEInsertneedlefullyintotheabdominal subcutaneoustissueKnowthatuseofalcoholorbenzodiazepineswithbuprenorphineincreasestheriskofoverdoseanddeathThisonce-monthlydoseof SublocadedeliverssteadylevelsofbuprenorphineintothebloodPeoplemustbetakingsublingualbuprenorphinebeforestartingSublocadeUnderstandthe importanceofinformingprovidersiftheybecomepregnantSUBLOCADEEducationBrochureSUBLOCADE®(buprenorphineextended-release)injection,for subcutaneoususe(CIII)Tellyourhealthcareprovideraboutallthemedicinesyoutake,includingprescriptionandover-the-countermedicines,vitaminsandherbal supplementsSUBLOCADEcontainsbuprenorphine,apartialopioidagonist,andisindicatedforthetreatmentofmoderatetosevereopioidusedisorderin patientswhohaveinitiatedtreatmentwithaWhattoKnowandExpecttheabdominalregionSublocade(ortheshot)isonewayoftakingbuprenorphine,a medicationusedtotreataddictiontoopioids(heroin,fentanyl,orpainpills)Issued/;Title:MedicationGuideSUBLOCADE®(buprenorphineextended-release) injection,forsubcutaneoususe(CIII)SUBLOCADEshouldonlybepreparedandadministeredbyahealthcareproviderSUBLOCADEisaprescription medicineusedtotreatadultswithmoderatetosevereaddiction(dependence)toopioiddrugs(prescriptionorillegal)who:havereceived1,·SUBLOCADE containsbuprenorphine,apartialopioidagonist,andisindicatedforthetreatmentofmoderatetosevereopioidusedisorderinpatientswhoSUBLOCADE containsbuprenorphine,apartialopioidagonist,andisindicatedforthetreatmentofmoderatetosevereopioidusedisorderinpatientswhohaveinitiated DistributedbyBraeburn,Inc,PlymouthMeeting,PA,USAManufacturedby:PharmaceuticsInternational,Inc(Pii),CockeysvilleMDFormoreinformation,go toorcallThisMedicationGuidehasbeenapprovedbytheUSFoodandDrugAdministration